[Claforan concentration in wound secretion following intravenous, intra-arterial, and regional intravenous infusion in patients with stage IV arterial occlusive diseases of the lower extremities].
Acevedo
A
A
Servicio de Cirugía, Hospital Salvador, Santiago, Chile.
Schoop
W
W
D001157:Arterial Occlusive Diseases / Q000097:blood* / Q000188:drug therapy*; D002439:Cefotaxime / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D006801:Humans; D007261:Infusions, Intra-Arterial; D007262:Infusions, Intravenous; D008297:Male; D008657:Metabolic Clearance Rate / Q000502:physiology; D008875:Middle Aged
D002439:Cefotaxime
Claforankonzentration im Wundsekret nach intravenöser (IV), intraarterieller (IA), und regionären IV (RIV) Infusion an Patienten mit arteriellen Durchblutungsstörungen der unteren Extremitäten im Stadium IV.